Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
32 studies found for:    " December 19, 2012":" January 18, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" December 19, 2012":" January 18, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Folinic Acid and Vascular Reactivity in HIV
Condition: Human Immunodeficiency Virus (HIV) Infection
Interventions: Dietary Supplement: Folinic Acid;   Other: Placebo
2 Completed Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir
Conditions: Hepatitis C, Chronic;   HIV Infection
Interventions: Drug: Ritonavir withdrawal, atazanavir 200 mg/12h;   Drug: Telaprevir interactions
3 Recruiting Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy
Condition: Human Immunodeficiency Virus
Interventions: Drug: Raltegravir;   Drug: Fluconazole;   Drug: Azithromycin;   Drug: Albendazole;   Drug: Isoniazid;   Dietary Supplement: Ready to Use Supplementary Food
4 Active, not recruiting Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: E/C/F/TAF;   Drug: E/C/F/TDF;   Drug: Placebo to match E/C/F/TDF;   Drug: Placebo to match E/C/F/TAF
5 Active, not recruiting Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission
Condition: HIV
Intervention: Behavioral: comprehensive intervention components
6 Completed Randomized Control Trial of Shang Ring Versus Forceps-guided Adult Male Circumcision in Southwestern Uganda.
Condition: HIV
Interventions: Procedure: Shang Ring Guided Circumcision;   Procedure: Forceps Guided Circumcision
7 Recruiting Effects of Newly-Initiated QUAD Therapy on Aortic/Coronary Inflammation in ART-Naïve Infected Patients
Condition: HIV
Intervention:
8 Recruiting Palliative Care in People Living With HIV/AIDS: Integrating Into Standard of Care
Condition: HIV
Interventions: Behavioral: FAmily-CEntered Advance Care Planning;   Behavioral: Healthy Living Control
9 Not yet recruiting Steady State PK in Malnourished HIV Infected Children
Conditions: HIV Positive;   Malnourished
Intervention: Drug: ZDV+3TC+LPV/r
10 Recruiting CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
Condition: HIV
Intervention: Behavioral: CVCTPLUS
11 Active, not recruiting Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).
Condition: HIV Infection
Intervention: Drug: FTC/TDF (Truvada®)
12 Active, not recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
13 Active, not recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
14 Completed A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir 50 mg;   Drug: Calcium Carbonate  1200 mg;   Drug: Ferrous Fumarate 324 mg
15 Recruiting The HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial
Condition: Rapid HIV Screening
Interventions: Other: A: Nontargeted rapid HIV screening;   Other: B: Enhanced targeted rapid HIV screening;   Other: C: Traditional targeted rapid HIV screening
16 Recruiting Pediatric HIV Disclosure Intervention
Condition: Paediatric HIV Diagnosis Disclosure
Intervention: Behavioral: Cognitive behavioral intervention to support pediatric HIV disclosure
17 Unknown  Rosuvastatin to Decrease Residual Immune Activation in HIV Infection
Condition: HIV-1 Infection
Intervention: Drug: Rosuvastatin 20 mg/day
18 Recruiting Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent
Condition: HIV-1
Intervention:
19 Recruiting Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)
Conditions: Visceral Leishmaniasis;   Human African Trypanosomiasis;   Enteric Fever;   Melioidosis;   Brucellosis;   Leptospirosis;   Relapsing Fever;   Rickettsial Diseases;   HIV;   Tuberculosis;   Malaria;   Amoebic Liver Abscess
Interventions: Device: rk28 ICT;   Device: IT LEISH (rK39);   Device: Immunochromatographic HAT test;   Device: HAT Serostrip;   Device: Card Agglutination Trypanosoma Test (CATT)-10;   Device: Typhidot M;   Device: S. typhi IgM/IgG;   Device: Test-it Typhoid IgM;   Device: Test-it Leptospirosis IgM;   Device: Leptospira IgG/IgM
20 Active, not recruiting Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers
Conditions: Heavy Drinking;   HIV;   Alcohol Dependence
Interventions: Drug: Topiramate;   Behavioral: Medical Management

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Indicates status has not been verified in more than two years